Biotech · Private company · Houston, TX, US
NXTech
Track this companyFree. Adds NXTech to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- mHealthPhase 1 · AddictionClinicalTrials.gov · fetched Nov 12, 2026
- mHealth application (custom)Phase 1 · Cognitive Function AbnormalClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Boost Study 31380 (mHealth)PHASE1 · COMPLETED · started Apr 18, 2022ClinicalTrials.gov NCT05757453 · fetched Nov 12, 2026
- Boost Study 21270 (Cognition)EARLY_PHASE1 · COMPLETED · started Apr 18, 2022ClinicalTrials.gov NCT05990335 · fetched Nov 12, 2026
NIH awards2
- BoostPrime, A Novel Digital Therapeutic for Craving Mitigation in OUDFiscal year 2026 · $1MNIH RePORTER 5R44DA058531-03 · fetched Nov 12, 2026
- BoostPrime, A Novel Digital Therapeutic for Craving Mitigation in OUDFiscal year 2025 · $1.2MNIH RePORTER 4R44DA058531-02 · fetched Nov 12, 2026